Reuters exclusively reports black market in Russian for HIV drug to try on coronavirus

Reuters exclusively reported that a black market has developed in Russia for an antiviral HIV drug explored as a possible treatment for COVID-19. “Three months ago, people were buying Kaletra from us without much enthusiasm for 900 roubles ($12) a box,” a Reuters source said. “Now, anticipating (supply) interruptions, people are buying between 100 and 700 boxes from us, at 3,800 roubles a box. Mainly, people are buying (Kaletra) with the aim of reselling it for a very high price.”